Shire Pharmaceuticals pays $56.5 million to settle False Claims Act case for fraudulent marketing

Pharmaceutical company Shire Pharmaceuticals LLC will pay $56.5 million to settle civil allegations that it violated the False Claims Act as a result of its marketing and promotion of several drugs, the Justice Department announced today. Shire, located in Wayne, Pennsylvania, manufactures and sells pharmaceuticals, including Adderall XR, Vyvanse and Daytrana, which...
Continue reading…

Pharmacy PharMerica pays $31.5 Million settling whistleblower suit alleging drug distribution without physician ok

Long-Term Care Pharmacy to Pay $31.5 Million to Settle Lawsuit Alleging Violations of Controlled Substances Act and False Claims Act, according to the United States Department of Justice. The False Claims Act claims resolved by today's settlement were originally brought by whistleblower Jennifer Denk, a pharmacist formerly employed by PharMerica, under the...
Continue reading…

Drug maker Cephalon sanctioned for paying competition not to make generic version of Privigil

A new scheme has entered the pharmaceutical industry involving what the courts have now deemed as illegal payoffs in which drug-makers holding patents, sue generic manufacturers then settle the case paying millions to keep them from making the less expensive version. Pharmaceutical manufacturer Cephalon was sanctioned by the Federal Trade Commission for the so called...
Continue reading…